Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Its business is in the development and commercialization of innovative assay platforms, based on the company’s expertise in surface chemistry and engineering.

New Asia Investments had invested in the company via NA Singapore Early-Stage Venture Fund I Pte Ltd in 2009. The stake was sold to Zicom Inc., a Singaporean/ Australian conglomerate listed on the Australian Stock Exchange, in 2010.